Log in to save to my catalogue

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelinati...

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelinati...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5800335

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination

About this item

Full title

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination

Publisher

England: BMJ Publishing Group LTD

Journal title

Journal of neurology, neurosurgery and psychiatry, 2018-02, Vol.89 (2), p.127-137

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group LTD

Subjects

Subjects and topics

More information

Scope and Contents

Contents

ObjectiveWe characterised the clinical course, treatment and outcomes in 59 patients with relapsing myelin oligodendrocyte glycoprotein (MOG) antibody-associated demyelination.MethodsWe evaluated clinical phenotypes, annualised relapse rates (ARR) prior and on immunotherapy and Expanded Disability Status Scale (EDSS), in 218 demyelinating episodes...

Alternative Titles

Full title

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5800335

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5800335

Other Identifiers

ISSN

0022-3050

E-ISSN

1468-330X

DOI

10.1136/jnnp-2017-316880

How to access this item